This webinar hosted by our partner Mirus Bio, presents new case study data from Artis BioSolutions showcasing how to optimize AAV2 and AAV9 production.
As an attendee, you will see how the choice of transfection platform can affect titer, cost per dose, and capsid quality across multiple production scales.
The speakers will also demonstrate how transfection complex stabilization can further improve process scalability and product quality.
If these are factors you’re considering, this webinar may be worth a closer look.
